|
NL293572A
(enExample)
*
|
1962-06-07 |
|
|
|
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
JP2004529100A
(ja)
|
2001-01-30 |
2004-09-24 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
スフィンゴシン−１−ホスフェートレセプターのアゴニストおよびアンタゴニスト
|
|
WO2002079131A1
(en)
|
2001-03-29 |
2002-10-10 |
Kansai Research Institute, Inc. |
Optically active compound and photosensitive resin composition
|
|
ES2316613T3
(es)
|
2001-05-10 |
2009-04-16 |
Ono Pharmaceutical Co., Ltd. |
Derivados de acido crboxilico y composiciones farmaceuticas que contienen los mismos como ingrediente activo.
|
|
CA2461212C
(en)
|
2001-09-27 |
2010-08-17 |
Kyorin Pharmaceutical Co., Ltd. |
Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
|
|
JP2005516967A
(ja)
|
2002-01-18 |
2005-06-09 |
ザ ジェネティクス カンパニー インコーポレーティッド |
β−セクレターゼインヒビター
|
|
JP4430941B2
(ja)
|
2002-01-18 |
2010-03-10 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬
|
|
WO2003061567A2
(en)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
WO2003074008A2
(en)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
JP2005533058A
(ja)
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
|
|
AU2003252478A1
(en)
|
2002-07-10 |
2004-02-02 |
Ono Pharmaceutical Co., Ltd. |
Ccr4 antagonist and medicinal use thereof
|
|
US7241790B2
(en)
|
2002-07-30 |
2007-07-10 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
|
CA2505322A1
(en)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
DE60335827D1
(de)
|
2002-12-20 |
2011-03-03 |
Merck Sharp & Dohme |
1-(amino)indane als edg-rezeptoragonisten
|
|
PL378134A1
(pl)
|
2003-02-11 |
2006-03-06 |
Irm Llc |
Nowe pochodne bicykliczne i kompozycje farmaceutyczne zawierające pochodne bicykliczne
|
|
BRPI0407658A
(pt)
|
2003-02-18 |
2006-02-21 |
Kyorin Seiyaku Kk |
derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
|
|
US7329680B2
(en)
|
2003-04-30 |
2008-02-12 |
The Institute For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids
|
|
CN1777575B
(zh)
|
2003-04-30 |
2010-05-12 |
诺瓦提斯公司 |
作为1-磷酸-鞘氨醇受体调节剂的氨基-丙醇衍生物
|
|
MXPA05011597A
(es)
|
2003-04-30 |
2005-12-15 |
Novartis Ag |
Derivados de aminopropanol como moduladores del receptor 1-fosfato de esfingosina.
|
|
AU2004240586A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
|
CL2004001120A1
(es)
|
2003-05-19 |
2005-04-15 |
Irm Llc |
Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
|
|
EP1644367B1
(en)
|
2003-05-19 |
2015-10-14 |
Novartis AG |
Immunosuppressant compounds and compositions
|
|
MXPA05012459A
(es)
|
2003-05-19 |
2006-02-22 |
Irm Llc |
Compuestos y composiciones inmunosupresoras.
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
JPWO2005012221A1
(ja)
|
2003-08-04 |
2006-09-14 |
小野薬品工業株式会社 |
ジフェニルエーテル化合物、その製造方法および用途
|
|
ATE449069T1
(de)
|
2003-08-28 |
2009-12-15 |
Novartis Pharma Gmbh |
Aminopropanolderivate
|
|
US7825109B2
(en)
|
2003-08-29 |
2010-11-02 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
WO2005023771A1
(ja)
|
2003-09-05 |
2005-03-17 |
Ono Pharmaceutical Co., Ltd. |
ケモカインレセプターアンタゴニストおよびその医薬用途
|
|
US20070043014A1
(en)
|
2003-10-01 |
2007-02-22 |
Merck & Co., Inc. |
3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
|
WO2005044780A1
(ja)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
|
|
EP1697333A4
(en)
|
2003-12-17 |
2009-07-08 |
Merck & Co Inc |
(3,4-DISUBSTITUTED) PROPANE ACID BOXYLATES AS AGONISTS OF THE S1P (EDG) RECEPTOR
|
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
US7718704B2
(en)
|
2004-02-24 |
2010-05-18 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
NZ549162A
(en)
|
2004-02-24 |
2009-12-24 |
Sankyo Co |
Amino-pyrrol alcohol compounds
|
|
CN1934094A
(zh)
|
2004-03-05 |
2007-03-21 |
万有制药株式会社 |
二芳基取代杂环5元环衍生物
|
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
|
JP5239071B2
(ja)
|
2004-04-02 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
シクロアルカノインドール誘導体の調製のために有用な非対称水素化方法
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
Ｓ１ｐ受容体結合能を有する化合物およびその用途
|
|
US7781617B2
(en)
|
2004-07-16 |
2010-08-24 |
Kyorin Pharmaceutical Co., Ltd |
Effective use method of medicaments and method of preventing expression of side effect
|
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
|
US8022225B2
(en)
|
2004-08-04 |
2011-09-20 |
Taisho Pharmaceutical Co., Ltd |
Triazole derivative
|
|
MX2007001661A
(es)
|
2004-08-13 |
2007-04-23 |
Praecis Pharm Inc |
Metodos y composiciones para modular la actividad del receptor de esfingosina -1 fosfato (sip).
|
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
|
WO2006034337A2
(en)
|
2004-09-23 |
2006-03-30 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
|
|
CA2583947A1
(en)
|
2004-10-12 |
2006-04-20 |
Forbes Medi-Tech (Research) Inc. |
Compounds and methods of treating insulin resistance and cardiomyopathy
|
|
CA2583681A1
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
|
PL1650186T3
(pl)
|
2004-10-22 |
2008-11-28 |
Bioprojet Soc Civ |
Nowe pochodne kwasów dikarboksylowych
|
|
JP2008520692A
(ja)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環置換カルボン酸
|
|
JPWO2006057448A1
(ja)
|
2004-11-26 |
2008-06-05 |
武田薬品工業株式会社 |
アリールアルカン酸誘導体
|
|
WO2006063033A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
|
BRPI0519012A2
(pt)
|
2004-12-13 |
2008-12-23 |
Ono Pharmaceutical Co |
derivado do Ácido aminocarboxÍlico e seu uso medicinal
|
|
DE112005003337T5
(de)
|
2005-01-25 |
2008-02-21 |
Merck Patent Gmbh |
Mesogene Verbindungen, Flüssigkristallmedium und Flüssigkristallanzeige
|
|
US7754703B2
(en)
|
2005-02-14 |
2010-07-13 |
University Of Virginia Patent Foundation |
Cycloalkane-containing sphingosine 1-phosphate agonists
|
|
KR20080002850A
(ko)
|
2005-03-23 |
2008-01-04 |
액테리온 파마슈티칼 리미티드 |
신규한 티오펜 유도체
|
|
CA2602474C
(en)
|
2005-03-23 |
2014-06-10 |
Actelion Pharmaceuticals Ltd |
Hydrogenated benzo (c) thiophene derivatives as immunomodulators
|
|
US7605269B2
(en)
|
2005-03-23 |
2009-10-20 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
|
|
WO2006131336A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
|
|
US7951794B2
(en)
|
2005-06-24 |
2011-05-31 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives
|
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ｐｐａｒ調節劑之醫藥組成物的用途
|
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
|
BRPI0615133A2
(pt)
|
2005-08-23 |
2011-05-03 |
Irm Llc |
compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
|
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
|
EP1965807A4
(en)
|
2005-11-23 |
2010-10-27 |
Epix Delaware Inc |
S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE
|
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2007209051A1
(en)
|
2006-01-24 |
2007-08-02 |
Actelion Pharmaceuticals Ltd |
Novel pyridine derivatives
|
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
|
JP2009526073A
(ja)
|
2006-02-09 |
2009-07-16 |
ユニバーシティ オブ バージニア パテント ファンデーション |
二環式スフィンゴシン−１−リン酸受容体アナログ
|
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
|
AU2007214434B2
(en)
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
KR20080096780A
(ko)
|
2006-02-21 |
2008-11-03 |
유니버시티 오브 버지니아 페이턴트 파운데이션 |
Ｓ１ｐ 수용체 효능제로서의 페닐-시클로알킬 및 페닐-헤테로시클릭 유도체
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
MX2008011615A
(es)
|
2006-03-14 |
2008-09-22 |
Amgen Inc |
Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
|
|
AU2007227274A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1P receptor modulating compounds
|
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
|
PL2003132T3
(pl)
|
2006-04-03 |
2014-10-31 |
Astellas Pharma Inc |
Pochodne oksadiazolu jako agoniści S1P1
|
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
|
WO2007129473A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
二環性アリール誘導体
|
|
EP2258700A1
(en)
|
2006-05-09 |
2010-12-08 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
|
WO2007129745A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
ヘテロアリールアミド低級カルボン酸誘導体
|
|
EP2046766A1
(en)
|
2006-08-01 |
2009-04-15 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine- 1- phosphate receptor (slp)
|
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
|
JP2009545630A
(ja)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
化合物
|
|
CA2659598A1
(en)
|
2006-08-08 |
2008-02-14 |
Kyorin Pharmaceutical Co., Ltd. |
Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
|
|
EP2054377A1
(en)
|
2006-08-24 |
2009-05-06 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
PT2069336E
(pt)
|
2006-09-07 |
2013-03-07 |
Actelion Pharmaceuticals Ltd |
Derivados de piridin-4-ilo como agentes imunomoduladores
|
|
CA2662852A1
(en)
|
2006-09-07 |
2008-03-13 |
Allergan, Inc. |
Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
|
|
AR061841A1
(es)
|
2006-09-07 |
2008-09-24 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores.
|
|
KR20090060333A
(ko)
|
2006-09-08 |
2009-06-11 |
노파르티스 아게 |
림프구 상호작용에 의해 매개되는 질환의 치료에 유용한 ｎ-바이아릴 (헤테로)아릴술폰아미드 유도체
|
|
ES2393412T3
(es)
|
2006-09-21 |
2012-12-21 |
Actelion Pharmaceuticals Ltd. |
Derivados de fenilo y su uso como inmunomoduladores
|
|
EP2109364A4
(en)
|
2006-12-15 |
2010-04-14 |
Abbott Lab |
NOVEL OXADIAZONE COMPOUNDS
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0720478A2
(pt)
|
2006-12-21 |
2014-01-14 |
Abbott Laboratoires |
Compostos agonistas e antagonistas do receptor esfingosina-1-fosfato
|
|
JO2701B1
(en)
*
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
|
MX2009007334A
(es)
|
2007-01-11 |
2009-07-15 |
Allergan Inc |
Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p).
|
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
BRPI0808789A2
(pt)
|
2007-03-16 |
2014-08-12 |
Actelion Pharmaceuticals Ltd |
Compostos e composição farmacêutica de derivados aminopiridina e uso destes
|
|
JP5191497B2
(ja)
|
2007-03-21 |
2013-05-08 |
エピックス ファーマシューティカルズ，インコーポレイテッド |
Ｓ１ｐ受容体調節化合物およびその使用
|
|
AU2008240773B2
(en)
|
2007-04-19 |
2013-10-03 |
Glaxo Group Limited |
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
|
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
CN101790519B
(zh)
|
2007-08-08 |
2013-10-16 |
默克雪兰诺有限公司 |
用于治疗多发性硬化症的结合于鞘氨醇1-磷酸(s1p)的6-氨基-嘧啶-4-羧酰胺衍生物及相关化合物
|
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
|
EP2222668B1
(en)
|
2007-12-18 |
2011-11-02 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
EP2252615A1
(en)
|
2008-01-25 |
2010-11-24 |
Arena Pharmaceuticals, Inc. |
Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists
|
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
|
EP3782991A1
(en)
|
2008-05-14 |
2021-02-24 |
The Scripps Research Institute |
Novel modulators of sphingosine phosphate receptors
|
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
US8580841B2
(en)
|
2008-07-23 |
2013-11-12 |
Arena Pharmaceuticals, Inc. |
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
HRP20160890T1
(hr)
*
|
2008-08-27 |
2016-09-23 |
Arena Pharmaceuticals, Inc. |
Derivati supstituirane tricikličke kiseline kao agonisti s1p1-receptora korisni u liječenju autoimunih i upalnih poremećaja
|
|
MX2011005954A
(es)
*
|
2008-12-05 |
2011-10-11 |
Astellas Pharma Inc |
Compuesto de 2h-cromeno y su derivado.
|
|
PE20120578A1
(es)
|
2009-02-10 |
2012-06-17 |
Abbott Lab |
Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos
|
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
|
US9216972B2
(en)
|
2009-10-29 |
2015-12-22 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
|
JP5856980B2
(ja)
|
2010-01-27 |
2016-02-10 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
|
|
CN105503882B
(zh)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
制备s1p1受体调节剂及其晶体形式的方法
|
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|